← Leaderboards
Saleem Drera
Radtran Llc
$355,000
Attributed
$355,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2021–22$500K$375K$250K$125K$0
'21
'22
Funding mix
By agency
NIH$355,000 · 1
By mechanism
R43$355,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Radioisotopes”
- Graham Bench · Lawrence Livermore National Security, Llc$6,490,542
- Zachary Scott Morris · University Of Wisconsin-Madison$5,329,564
- Michael King Schultz · Viewpoint Molecular Targeting, Inc.$4,191,849
- Anna Lisa Somera · Rhaeos, Inc.$4,059,841
- Sarah Marie Cheal · Weill Medical Coll Of Cornell Univ$3,628,213
- Daniel Lyndon Jaffe Thorek · Johns Hopkins University$3,591,750
Research focus
RadioisotopesIsotopesPharmaceutical PreparationsCancerousMiningCellsMedicalPeptidesRadiumThoriumProductionOncologyCategoriesCancer TherapyBaseCancer Radionuclide TherapyCancer PatientAntibodiesAgreementCost EffectiveConsciousCommercializationCoupledClinical Trials
Grant awards (2)
I-Corps: The utility of a mining byproduct, thorium, and a novel radium separation technique to provide full value chain radioisotope supply for Ra224, Ac225, and Pb212 oncology drugs$55,000
R43 · FY2022 · CA · contact PI
The utility of a mining byproduct, thorium, and a novel radium separation technique to provide full value chain radioisotope supply for Ra224, Ac225, and Pb212 oncology drugs$300,000
R43 · FY2021 · CA · contact PI